Page last updated: 2024-09-02

ecteinascidin 743 and Sarcopenia

ecteinascidin 743 has been researched along with Sarcopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armento, G; Badalamenti, G; Catania, G; Incorvaia, L; Maltese, G; Napolitano, A; Santini, D; Silletta, M; Spalato Ceruso, M; Tonini, G; Valeri, S; Vincenzi, B	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Sarcopenia

Article	Year
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin. Oncology, 2018, Volume: 95, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Dioxoles; Female; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Sarcoma; Sarcopenia; Tetrahydroisoquinolines; Thinness; Trabectedin	2018

Article

Year

Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.

Oncology, 2018, Volume: 95, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Dioxoles; Female; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Sarcoma; Sarcopenia; Tetrahydroisoquinolines; Thinness; Trabectedin

2018